CD30: seeing is not always believing

被引：10

作者：

Blum, Kristie A. ^{[1
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

来源：

BLOOD | 2015年 / 125卷 / 09期

关键词：

B-CELL LYMPHOMA; BRENTUXIMAB VEDOTIN; LENALIDOMIDE; EXPRESSION; DLBCL;

D O I：

10.1182/blood-2015-01-622480

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1358 / 1359

页数：4

共 10 条

[1]

[Anonymous], BLOOD

[2] A Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory CD30-Positive Non-Hodgkin Lymphomas: Interim Results In Patients With DLBCL and Other B-Cell Lymphomas [J].

Bartlett, Nancy L. ;

Sharman, Jeff P. ;

Oki, Yasuhiro ;

Advani, Ranjana H. ;

Bello, Celeste M. ;

Winter, Jane N. ;

Yang, Yin ;

Kennedy, Dana A. ;

Jacobsen, Eric D. .

BLOOD, 2013, 122 (21)

[3] Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels [J].

Bossard, Celine ;

Dobay, Maria Pamela ;

Parrens, Marie ;

Lamant, Laurence ;

Missiaglia, Edoardo ;

Haioun, Corinne ;

Martin, Antoine ;

Fabiani, Bettina ;

Delarue, Richard ;

Tournilhac, Olivier ;

Delorenzi, Mauro ;

Gaulard, Philippe ;

de Leval, Laurence .

BLOOD, 2014, 124 (19) :2983-2986

[4] Higher Response to Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nongerminal Center B-Cell-Like Than in Germinal Center B-Cell-Like Phenotype [J].

Hernandez-Ilizaliturri, Francisco J. ;

Deeb, George ;

Zinzani, Pier L. ;

Pileri, Stefano A. ;

Malik, Farhana ;

Macon, William R. ;

Goy, Andre ;

Witzig, Thomas E. ;

Czuczman, Myron S. .

CANCER, 2011, 117 (22) :5058-5066

[5] CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study [J].

Hu, Shimin ;

Xu-Monette, Zijun Y. ;

Balasubramanyam, Aarthi ;

Manyam, Ganiraju C. ;

Visco, Carlo ;

Tzankov, Alexander ;

Liu, Wei-min ;

Miranda, Roberto N. ;

Zhang, Li ;

Montes-Moreno, Santiago ;

Dybkaer, Karen ;

Chiu, April ;

Orazi, Attilio ;

Zu, Youli ;

Bhagat, Govind ;

Richards, Kristy L. ;

Hsi, Eric D. ;

Choi, William W. L. ;

van Krieken, J. Han ;

Huang, Qin ;

Huh, Jooryung ;

Ai, Weiyun ;

Ponzoni, Maurilio ;

Ferreri, Andres J. M. ;

Zhao, Xiaoying ;

Winter, Jane N. ;

Zhang, Mingzhi ;

Li, Ling ;

Moller, Michael B. ;

Piris, Miguel A. ;

Li, Yong ;

Go, Ronald S. ;

Wu, Lin ;

Medeiros, L. Jeffrey ;

Young, Ken H. .

BLOOD, 2013, 121 (14) :2715-2724

[6] Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression [J].

Jacobsen, Eric D. ;

Sharman, Jeff P. ;

Oki, Yasuhiro ;

Advani, Ranjana H. ;

Winter, Jane N. ;

Bello, Celeste M. ;

Spitzer, Gary ;

Palanca-Wessels, Maria Corinna ;

Kennedy, Dana A. ;

Levine, Pamela ;

Yang, Jing ;

Bartlett, Nancy L. .

BLOOD, 2015, 125 (09) :1394-1402

[7] Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study [J].

Pro, Barbara ;

Advani, Ranjana ;

Brice, Pauline ;

Bartlett, Nancy L. ;

Rosenblatt, Joseph D. ;

Illidge, Tim ;

Matous, Jeffrey ;

Ramchandren, Radhakrishnan ;

Fanale, Michelle ;

Connors, Joseph M. ;

Yang, Yin ;

Sievers, Eric L. ;

Kennedy, Dana A. ;

Shustov, Andrei .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2190-2196

[8] Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation [J].

Vose, Julie M. ;

Habermann, Thomas M. ;

Czuczman, Myron S. ;

Zinzani, Pier Luigi ;

Reeder, Craig B. ;

Tuscano, Joseph M. ;

Lossos, Izidore S. ;

Li, Ju ;

Pietronigro, Dennis ;

Witzig, Thomas E. .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (05) :639-647

[9]

Yasenchak CA, 2015, BLOOD, V126

[10] Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma [J].

Younes, Anas ;

Gopal, Ajay K. ;

Smith, Scott E. ;

Ansell, Stephen M. ;

Rosenblatt, Joseph D. ;

Savage, Kerry J. ;

Ramchandren, Radhakrishnan ;

Bartlett, Nancy L. ;

Cheson, Bruce D. ;

de Vos, Sven ;

Forero-Torres, Andres ;

Moskowitz, Craig H. ;

Connors, Joseph M. ;

Engert, Andreas ;

Larsen, Emily K. ;

Kennedy, Dana A. ;

Sievers, Eric L. ;

Chen, Robert .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2183-2189

← 1 →